Swedish snus have been linked to pancreatic cancer, this finding was revealed in articles published in the online edition of The Lancet. This is an oral tobacco; it is smoke free and has been proven to be less harmful than the traditional tobacco that is being smoked. Smokers who choose to switch to Swedish Snus will have no risk of getting mouth cancer or lungs cancer. The Lancet have however published that the users of the Snus have double the chances of getting pancreatic cancer than those that have never smoked.
This articles authority is from the School of Population Health, University of Queensland in Australia. There Dr Coral Gartner and his colleagues attempted to estimate the difference in the lifespan of people that never smoked against the people that use tobacco. The tobacco users were not limited only to those that were using snus.
Their research showed that there was little difference in the lie expectancy from those who stop smoking tobacco and those who switch to the use of snus.
The conclusion of the research was that those who switched from tobacco to snus rather than continue smoking will have a good amount of health benefits. The author opined that rather than continue smoking tobacco, it would be safer to switch to snus, as this will be benefit them more. The author further called for the restrictions that are on the sales of snus to be lifted. This will help more inveterate smokers to easily make the switch to snus. The restriction the author believes will bring more good than harm to the society.
In a second article by The Lancet, Dr Olof Nyren and his colleagues from the Clinical Epidemiology Unit, Karolinska Institute in Sweden carried out their study on 280000 construction workers that had a dependency on tobacco from 1978 to 1992 and still observed and studied them until 2004. Their focus on the construction worker was to observe their tobacco consumption and habits.
The result of their studies showed that the risk of getting lung or mount cancer did not differ amongst both the snus users and the non smokers. However, the snus user are twice more likely to end up with a pancreatic cancer than the non smokers. The smokers’ chances of getting pancreatic cancer are still higher than the snus users.
The authors’ opinion at the end of the study is that the use of the Swedish moist snus does not increase the chances of having cancer as there are no carcinogenic risks involved. This opinion when validated will have important role in helping to reduce the dangers that the nicotine addicts face. Snus will then be a recommendable substitute to help with nicotine addiction.
Reacting to this article, tobacco dependence program, University of Medicine and Dentistry, New Jersy School of Public health has called that snus should be allowed to compete alongside with cigarettes. These researches are believed to help in the opposition against snus. The delay in allowing snus to compete with cigarettes should end.